Gilead Sciences
GILD
#129
Rank
NZ$260.36 B
Marketcap
NZ$209.83
Share price
-1.14%
Change (1 day)
35.16%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.29. In 2024 the company made an earnings per share (EPS) of NZ$0.66 a decrease over its 2023 EPS that were of NZ$7.88.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231606.68%
2024NZ$0.66-91.65%
2023NZ$7.8823.98%
2022NZ$6.35-25.86%
2021NZ$8.574850%
2020NZ$0.17-97.64%
2019NZ$7.340.9%
2018NZ$7.2718.71%
2017NZ$6.13-64.88%
2016NZ$17.45-18.45%
2015NZ$21.4055.28%
2014NZ$13.78296.02%
2013NZ$3.4817.89%
2012NZ$2.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.55 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.81 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.34-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.74-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.02 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.07 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.52 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.14 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA